Pharma Journalist
  • facebook
  • twitter
  • google_plus
  • Email
Pharma Journalist

Gilead Completes $7.8 Billion Arcellx Acquisition Deal

EU Approves Rhapsido for Chronic Hives Treatment

Lilly to Acquire Ajax in $2.3 Billion Deal

Merck and Siemens Extend Strategic Partnership to Drive Digital Transformation in Life Sciences

Read more

TegMine Therapeutics Partners with Boehringer Ingelheim to Develop Next-Gen Targeted Cancer Therapies

Read more

Biogen Provides Regulatory Update on High-Dose Nusinersen Regimen

Read more

Roche’s Giredestrant Shows Significant Progression-Free Survival Benefit in Phase III ER-Positive Breast Cancer Trial

Read more

Moderna’s mNEXSPIKE Shows Strong Immune Response Against LP.8.1 Variant in Humans

Read more

Eli Lilly to Build $6.5 Billion Manufacturing Facility in Houston, Boosting U.S. Drug Production

Read more

European Commission Approves Servier’s VORANIGO for Treatment of Grade 2 IDH-Mutant Glioma

Read more

US Regulatory Review Update: Tolebrutinib for Non-Relapsing Secondary Progressive MS

Read more

Minovia Therapeutics’ MNV-201 Granted FDA Fast Track Designation for Myelodysplastic Syndrome

Read more

Novo Nordisk: Ozempic Lowers Heart Attack, Stroke, and Death Risk by 23% vs. Dulaglutide in Real-World Study

Read more

Posts pagination

Previous Page 1 of 923 … Page 43 of 923 … Page 923 of 923 Next
  • About
  • Advertise
  • Subscribe
  • Contact
View Desktop Version